Korea Biomedical Review | IVI/WHO biomanufacturing trainees receive technical boost from Korean bioindustry
2022. 11. 14, 코리아 바이오메디칼 리뷰
The International Vaccine Institute (IVI) completed the second week of the three-week-long WHO Global Training Hub for Biomanufacturing (GTH-B) training program with a visit to Celltrion’s factory in Songdo, Incheon, on Friday.
This training program is the second WHO GTH-B program following the first course in standard biomanufacturing in July which trained 106 foreigners and 32 Koreans.
Dr. Jerome Kim (left), Director General of the International Vaccine Institute and Dr. Kyungjin Peter Kim, CEO of ST Pharm, pose for a photo as they exchange a memorandum of understanding at a signing ceremony at IVI headquarters in Seoul on November 24, 2022.